Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Surgery Partners (SGRY) Receives a Hold from Barclays

Tipranks - Tipranks - Wed Mar 4, 3:50AM CST

In a report released today, Andrew Mok CFA from Barclays maintained a Hold rating on Surgery Partners, with a price target of $14.00.

Claim 70% Off TipRanks Premium

According to TipRanks, Mok CFA is an analyst with an average return of -0.4% and a 51.00% success rate. Mok CFA covers the Healthcare sector, focusing on stocks such as Brookdale Senior Living, Humana, and Acadia Healthcare.

Currently, the analyst consensus on Surgery Partners is a Moderate Buy with an average price target of $21.33.

See today’s best-performing stocks on TipRanks >>

Based on Surgery Partners’ latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $821.5 million and a GAAP net loss of $22.7 million. In comparison, last year the company earned a revenue of $770.4 million and had a GAAP net loss of $31.7 million

Read More on SGRY:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).